Operose Advisors Portfolio holdings
Top Buys
| 1 |
Vanguard Total Stock Market ETF
VTI
|
+$5.23M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$2.91M |
| 3 |
iShares Core S&P Small-Cap ETF
IJR
|
+$2.06M |
| 4 |
Vanguard Mid-Cap ETF
VO
|
+$1.66M |
| 5 |
Schwab International Equity ETF
SCHF
|
+$1.62M |
Top Sells
| 1 |
iShares International Select Dividend ETF
IDV
|
+$687K |
| 2 |
UnitedHealth
UNH
|
+$436K |
| 3 |
Lockheed Martin
LMT
|
+$380K |
| 4 |
Qualcomm
QCOM
|
+$301K |
| 5 |
Invesco S&P International Developed Momentum ETF
IDMO
|
+$272K |
Sector Composition
| 1 | Technology | 6.67% |
| 2 | Financials | 3.85% |
| 3 | Communication Services | 2.88% |
| 4 | Consumer Discretionary | 1.89% |
| 5 | Healthcare | 1.47% |
Similar funds
Operose Advisors's Q3 2025 Portfolio in Review
As of Q3 2025, Operose Advisors held 472 positions worth $401M, up 13% from $355M the previous quarter. Its ten largest holdings account for 64% of the portfolio.
Operose Advisors deployed $21.3M of net new capital in Q3 2025, opening 62 new positions and adding to 92 existing holdings. Its largest new stake was Old National Bancorp: 26,244 shares worth $576K.
By sector, the portfolio is most concentrated in Technology at 6.7% of assets, up from 5.8% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was iShares International Select Dividend ETF, an estimated $687K trimmed.
- Operose Advisors's largest Q3 2025 buy was Old National Bancorp: 26,244 shares worth $576K.
- Operose Advisors added most to Vanguard Total Stock Market ETF in Q3 2025, an estimated $5.23M increase.
- Operose Advisors's biggest Q3 2025 reduction was iShares International Select Dividend ETF, cutting an estimated $687K.
- Operose Advisors fully exited Invesco S&P International Developed Momentum ETF in Q3 2025, selling an estimated $272K.
- Operose Advisors's ten largest holdings make up 64% of its $401M portfolio in Q3 2025.
- Operose Advisors opened 62 new positions and closed 28 in Q3 2025.
- Operose Advisors's portfolio value rose 13% quarter-over-quarter to $401M.
Based on Operose Advisors's 13F filing for Q3 2025, filed 12 Nov 2025.